Advertisement

Annals of Surgical Oncology

, Volume 3, Issue 6, pp 521–525 | Cite as

Kinetics of primary tumor regression with chemotherapy: Implications for the timing of surgery

  • Irene Medary
  • Daniel Aronson
  • Nai-Kong V. Cheung
  • Fereshteh Ghavimi
  • William Gerald
  • Michael P. La Quaglia
Original Articles

Abstract

Purpose: The kinetics of tumor regression during administration of chemotherapy has relevance to the timing of surgery. The aim of this study was characterization of the time course of primary tumor regression in initially unresectable rhabdomyosarcoma, hepatoblastoma, and neuroblastoma patients. We also estimated the total cell number in the primary tumor at diagnosis.

Methods: Tumor volumes of 24 pediatric patients with either unresectable rhabdomyosarcoma, hepatoblastoma, or neuroblastoma were determined by using computerized three-dimensional reconstruction from serial computed tomography (CT) scans during chemotherapy. Cell densities were calculated by counting cell numbers in high-power fields and dividing by area and section thickness. Cell number at diagnosis was then calculated.

Results: Median tumor volumes at diagnosis were 175 cc, 748 cc, and 738 cc for rhabdomyosarcoma, neuroblastoma, and hepatoblastoma, respectively. The median tumor cell counts were 31, 68, and 59 × 1010 cells/tumor for rhabdomyosarcoma, neuroblastoma, and hepatoblastoma, respectively. The tumor regression was most rapid during the first two cycles, and little change in volume was observed after three cycles.

Conclusion: Rapid initial reduction in primary tumor volume with chemotherapy was observed in rhabdomyosarcoma, neuroblastoma, and hepatoblastoma. These data suggest that second-look resection may be feasible after two to three cycles of chemotherapy. This hypothesis may be tested by randomizing the timing of second-look surgical intervention.

Key Words

Kinetics Regression Timing of surgery Pediatric cancer 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wheatley JM, Rosenfeld NS, Heller G, Feldstein D, La Quaglia MP. Validation of a technique of computer-aided tumor volume determination.J Surg Res 1995;59:621–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Maurer HM, Gehan EA, Beltangady M, et al. The Intergroup Rhabdomyosarcoma Study-II.Cancer 1993;71:1904–22.PubMedGoogle Scholar
  3. 3.
    Matsumura M, Atkinson JB, Hays DM, et al. An evaluation of the role of surgery in metastatic neuroblastoma.J Pediatr Surg 1988;23:448–53.PubMedGoogle Scholar
  4. 4.
    La Quaglia MP, Kushner BH, Heller G, Bonilla MA, Lindsley KL, Cheung NK. Stage IV neuroblastoma diagnosed at more than 1 year of age: gross total resection and clinical outcome.J Pediatr Surg 1994;29:1162–6.PubMedGoogle Scholar
  5. 5.
    Sitarz A, Finklestein J, Grosfeld J, et al. An evaluation of the role of surgery in disseminated neuroblastoma: a report from the Children's Cancer Study Group.J Pediatr Surg 1983;18:147–51.PubMedGoogle Scholar
  6. 6.
    Friedman MA, Resser KJ, Marcus FS. How accurate are computed tomographic scans in assessment of changes in tumor size?Am J Med 1983;75:193–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Cohen MD, Weber TR, Grosfeld J. Preoperative evaluation of pediatric abdominal tumors by computerized tomography.J Pediatr Surg 1984;19:273.PubMedGoogle Scholar
  8. 8.
    Gattani A, Chesser MR, Cuttner J, Bruckner HW. Serial assays of CA-125, CA-19-9, and CEA in newly treated patients with pancreatic cancer [Abstract].Proc Annu Meet Am Assoc Cancer Res 1992;33:A1305.Google Scholar
  9. 9.
    Cruickshank DJ, Terry PB, Fullerton WT. CA125-Response assessment in epithelial ovarian cancer.Int J Cancer 1992;51(1):58–61.PubMedGoogle Scholar
  10. 10.
    Goldie JH, Coldman AJ. A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate.Cancer Treat Rep 1979;63:1727–33.PubMedGoogle Scholar
  11. 11.
    Goldie JH, Coldman AJ. Quantitative model for multiple levels of drug resistance in clinical tumors.Cancer Treat Rep 1983;67:923–31.PubMedGoogle Scholar
  12. 12.
    De Vita VT Jr. Principles of chemotherapy. In: De Vita VTJr Hellman SA, Rosenberg SA, eds.Cancer: principles and practice of oncology. Philadelphia: JB Lippincott, 1985:257–83.Google Scholar

Copyright information

© The Society of Surgical Oncology, Inc. 1996

Authors and Affiliations

  • Irene Medary
    • 3
  • Daniel Aronson
    • 3
  • Nai-Kong V. Cheung
    • 1
  • Fereshteh Ghavimi
    • 1
  • William Gerald
    • 2
  • Michael P. La Quaglia
    • 3
  1. 1.Department of PediatricsMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  2. 2.Department of PathologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  3. 3.Department of Pediatric SurgeryMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations